Search results
Zepbound ® (ZEHP-bownd) is an injectable prescription medicine that may help adults with obesity, or with excess weight (overweight) who also have weight-related medical problems, lose weight and keep it off. It should be used with a reduced-calorie diet and increased physical activity.
Patients and health care providers are encouraged to report compounded or counterfeit Mounjaro or Zepbound by calling the Lilly Answers Center (TLAC) at 1-800-LillyRx (1-800-545-5979). Learn about our position on safety risks of using compounded tirzepatide.
INDICATION. Zepbound ® is indicated as an adjunct to a reduced-calorie diet and increased physical activity for chronic weight management in adults with an initial body mass index (BMI) of: 30 kg/m 2 or greater (obesity) or.
Zepbound is a once-a-week, single-dose injectable pen. Learn about dosing, how to inject and how to store and dispose of the Zepbound pen once you are finished.
Lilly USA, LLC. DOF-ZP-US-0017 as of 1/2024, and is subject to change without notice by a health plan or state. Please contact the plan or state for the most current information.
Zepbound is a once-weekly injectable prescription medicine for chronic weight management in adults with an initial body mass index of at least 30 kg/m2 or at least 27 kg/m2 with at least one weight-related comorbid condition.
There will be a pregnancy exposure registry that monitors pregnancy outcomes in women exposed to Zepbound (tirzepatide) during pregnancy. Pregnant patients exposed to Zepbound and healthcare providers are encouraged to contact Eli Lilly and Company at 1-800-LillyRx (1-800-545-5979).
